Adage Capital Management, L.P. 13D and 13G filings for BridgeBio Oncology Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 09:02 am Purchase | 2025-09-30 | 13G | BridgeBio Oncology Therapeutics Inc. BBOT | Adage Capital Management, L.P. | 1,487,621 1.880% | 1,487,621 (New Position) | Filing |